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Summary. In 17 patients with compensated autonomous adenomas 
of the thyroid, iv thyrotropin releasing hormone (TRH) tests 
(200 pg) and oral TRH tests (40 rag) were performed. In nine of 
these patients, thyroid-stimulating hormone (TSH) 30 min after 
iv TRH showed a normal (>2.7 ~U/ml) and in eight patients 
a subnormal (<2.7 gU/ml) or negative response. However, after 
prolonged oral stimulation with 40 mg TRH, after 120-180 rain 
TSH was normal (>2.7 laU/ml) in 15 and subnormal ( <2.7 pU/ml) 
in two patients. 
In 20 patients with decompensated autonomous thyroid nod- 
ules, TSH was not detectable ( <0.8 gU/ml) after iv or oral TRH 
stimulation. Therefore, theoral TRH stimulation test seemed to 
be superior to the iv TRH test in the discrimination ofcompensated 
and decompensated autonomous adenomas of the thyroid. 
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Ergebnisse des oralen TRH-Tests zur Unterscheidung 
yon kompensierten and dekompensierten autonomen Adenomen 
der Schilddriise 
Zusammenfassung. Bei 17 Patienten mit kompensierten autonomen 
Adenomen der Schilddr%e wurden TRH-Teste mit 200 gg i.v. und 
40 mg oral durchgeffihrt. Bei 9 Patienten war TSH 30 min nach 
TRH i.v. normal (> 2.7 ltU/ml), dagegen zeigten 8 Patienten einen 
subnormalen (<2.7 laU/ml) oder fehlenden TSH-Anstieg. Nach 
verlfingerter Stimulation mit 40 mg TRH oral war TSH 
120-180 min bei 15 Patienten im Normbereich (>2.7 pU/ml) und 
nur bei 2 Patienten subnormal (< 2.7 gU/ml). 
Bei 20 Patienten mit dekompensierten autonomen Adenomen 
der Schilddrtise lag TSH sowohl nach i.v. als auch nach oraler 
TRH-Stimuladon in allen F/illen unter der Nachweisgrenze 
( < 0.8 laU/ml). 
Die Befunde sprechen daf/ir, dab der orate TRH-Test geeig- 
neter ist als der i.v. TRH-Test, um zwischen kompensierten u d 
dekompensierten autonomen Adenomen der Schilddrfise zu unter- 
scheiden. 
Sehliissetw6rter: Autonomes Adenom - Oraler TRH-Test - Er- 
gebnisse 
Introduction 
Patients with scintigraphically decompensated autonomous thyroid 
nodules usually reveal negative intravenous 200 gg TRH tests [3]. 
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However. surprisingly comparable t st results have been obtained 
in about 30% of patients with scintigraphically compensated auton- 
omous adenomas [2]. Therefore, diagnosis of compensated and 
decompensated autonomous thyroid nodules is based primarily 
on scintigraphic findings and only to a small extent on the results 
of in vitro parameters of thyroid function. However, the oral TRH 
stimulation test was introduced recently and has been believed 
to be useful in the evaluation of patients with impaired TSH reserve 
but euthyroid function [I. 4, 5]. In these studies, about 10%-12% 
of apparently euthyroid patients revealed negative ntravenous 
200 lag TRH tests. In 50%-60% of these patients, autonomous 
production of thyroid hormones could be excluded by the 40-rag 
oral TRH test. It was the aim of this study to evaluate whether 
the oral TRH test is superior to the iv TRH test in the discrimina- 
tion of compensated and decompensated autonomous adenomas 
classified by nuclear imaging. 
Materials and Methods 
The study included a total of 37 outpatients (12 males and 25 
females) with an age ranging from 30 to 82 years. Diagnosis of 
autonomous thyroid nodules was based on the results of nuclear 
imaging with 99~Tc-pertechnate (employing a 20% uptake of the 
paranodular tissue as the discriminating value), including scintigra- 
phy, after suppression with 60 gg T3 tbr 10 days in cases uspected 
to have compensated autonomous adenomas. In all patients, intra- 
venous TRH tests were performed after an overnight fasting period 
with a boluslike injection f 200 gg TRH and TSH-RIA (Henning, 
Berlin), 30 rain aRer TRH application. For oral TRH tests, a 40 mg 
tablet of TRH (Thyroliberin, Merck, FRG) was used and single 
TSH determinations were done after 120-180 min. There was an 
interval of 2-6 weeks between the iv and oral TRH tests. T4 was 
measured by enzyme immunoassay (Syva Company, Palo Alto, 
USA) and T 3 by radio immunoassay (Amersham-Buchler, 
Braunschweig, FRG). 
Results 
In 17 patients (5 males and 12 females), scintigraphy after suppres- 
sion revealed a formerly compensated autonomous adenoma. Con- 
centrations of thyroid hormones were measured prior to appIica- 
tion ofT~. T 4 (5.4-10.8 ~tg/dl, 2=7.4 pg/dl) and T3 (1.0-2.9 ng/ml, 
2,:: 1.9 ng/ml) concentrations i  plasma were mainly in the normal 
range. 
Thyroid-stimulating hormone, 30 min after 200 gg iv TRH 
(0.8-14.6 gU/ml, 2=2.7 laU/ml), showed in nine patients a normal 
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(>2.7 btU/ml) and in eight patients a subnormal (<2.7 laU/ml) 
or negative response. However, TSH 120-180 min after 40 mg orat 
TRH was normal (>2.7 laU/ml) in 15 patients and subnormal 
(<2.7 gU/mt) in only two patients. 
In 20 patients (7 males and 13 females) scintigraphy demon- 
strated a primarily decompensated autonomous adenoma. In such 
cases, 30%-40% of T, (4.0-14.6gg/dl, 2=7.8~tg/dl) and T a 
(1,6 4.3 ng/ml, ~7=2.3 ng/ml) values were elevated. Thirty minutes 
after 200 gg iv TRH and 120-180 rain after 40 mg oral TRH, TSH 
was not detectable (<0.8 laU/ml) in all cases in accordance with 
the scintigraphic findings of decompensated autonomous thyroid 
nodules. 
Discussion 
Patients with scintigraphically decompensated autonomous thyroid 
nodules usually reveal negative iv 200 lag TRH tests. These data 
could be confirmed in the present study. 
Nearly 50% of the 17 patients with scintigraphically compen- 
sated autonomous thyroid nodules revealed a subnormal or nega- 
tive response to iv TRH in accordance with prior studies [2]. How- 
ever, prolonged stimulation with 40 mg oral TRH in these patients 
was associated with normal TSH response in 15 (88%) and subnor- 
mal in two (12%). All patients with decompensated autonomous 
thyroid nodules howed a failing TSH response to iv TRH and 
even to prolonged oral TRH stimulation. 
These findings point to a possible clinical validity of the oral 
TRH test as a help in the differentiation of compensated and 
decompensated autonomous adenomas, especially in borderline 
cases. In addition, in patients cintigraphically suspected to have 
compensated thyroid no ules, a negative result of an oral TRH 
test may help to exclude this diagnosis and prevent further diagnos- 
tic procedures, e.g., the T3-suppression-test. 
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